Education
About Us
Working with TipRanks
Follow Us
Raymond Cohen Insider Profile
11 Followers
Raymond Cohen, Director at Spectrum Pharmaceuticals, holds 40.90K shares in Kestra Medical Technologies Ltd. (Ticker: KMTS), holds 35.67K shares in RxSight (Ticker: RXST), holds 0.00 shares in Axonics Modulation Technologies (Ticker: AXNX).
Raymond Cohen Spectrum Pharmaceuticals (SPPI)Director
Spectrum Pharmaceuticals (SPPI)
Director
Ranked #90,043 out of 103,431 Corporate Insiders
Profitable Transactions
4 out of 11 Profitable Transactions
Average Return
-20.10%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Raymond Cohen holds in companies
Most Profitable Insider Trade
Stock:
Spectrum Pharmaceuticals
(SPPI)
(SPPI)
Rating:Informative Sell
Date:May 15, 2018 - May 15, 2019
Return:+50.20%
The most profitable trade made by Raymond Cohen
Raymond Cohen's Trading History
Spectrum Pharmaceuticals
Jun 21, 2019
―
Uninformative Buy
―
$55.47K
Axonics Modulation Technologies
Nov 15, 2024
―
Uninformative Sell
20.78M
$0.00
Kestra Medical Technologies Ltd.
Sep 08, 2025
Director
Uninformative Buy
―
$744.03K
RxSight
Aug 04, 2025
Director
Uninformative Buy
―
$357.39K
BioLife Solutions
Jul 14, 2021
Director
Uninformative Buy
―
$735.44K
List of latest transactions for each holding click on a transaction to see Raymond Cohen's performance on stock
You May Also Like
Raymond Cohen insider profile FAQ
What is the percentage of profitable transactions made by Raymond Cohen?
The percentage of profitable transactions made by Raymond Cohen is 36%.
What is the average return per transaction made by Raymond Cohen?
The average return per transaction made by Raymond Cohen is -20.10%.
What stocks does Raymond Cohen hold?
Raymond Cohen holds: SPPI, AXNX, KMTS, RXST, BLFS stocks.
What was Raymond Cohen’s latest transaction?
Raymond Cohen latest transaction was an Uninformative Buy of ―.
What was Raymond Cohen's most profitable transaction?
Raymond Cohen’s most profitable transaction was an Informative Sell of SPPI stock on May 15, 2018. The return on the trade was 50.20%.
What is Raymond Cohen's role in Spectrum Pharmaceuticals?
Raymond Cohen's role in Spectrum Pharmaceuticals is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.